Indiana University is leading the way in the development of groundbreaking nanotechnology to revolutionize screening for prostate cancer, the second leading cause of cancer death among men in the United States.
A professor in the Department of Biomedical Engineering and Informatics at the Luddy School of Informatics, Computing, and Engineering at IU Indianapolis, Mangilal Agarwal is working in collaboration with physicians and industry partners to adapt existing technology as well as develop new technology to produce more reliable and accurate prostate cancer screening methods. The work recently received support from a $1.2 million grant from the American Cancer Association.